期刊
NANOSCALE HORIZONS
卷 7, 期 8, 页码 908-915出版社
ROYAL SOC CHEMISTRY
DOI: 10.1039/d2nh00243d
关键词
-
资金
- DFG [SFB1066]
- Max Planck Society
Encapsulating multiple adjuvants and antigens into nanocarriers allows for synergistic induction of strong immune responses. A strategy to encapsulate a triple combination of adjuvants, including Resiquimod (R848), muramyl dipeptide (MDP), and polyinosinic-polycytidylic acid (Poly(I:C)), into human serum albumin (HSA) nanocarriers was developed. High encapsulation efficiency was achieved regardless of the physical properties of the cargoes, and the nanocarriers demonstrated efficient uptake and additive cell activation and maturation by dendritic cells.
Encapsulation of multiple adjuvants along with antigens into nanocarriers allows a co-delivery to antigen-presenting cells for the synergistic induction of robust immune responses. However, loading cargoes of different molar masses, polarities, and solubilities in high efficiencies remains a challenge. Therefore, we developed a strategy to encapsulate a triple combination of the so-called adjuvants, i.e. with Resiquimod (R848), muramyl dipeptide (MDP) and polyinosinic-polycytidylic acid (Poly(I : C)) into human serum albumin (HSA) nanocarriers. The loading is conducted in situ while the nanocarrier is formed by an orthogonal and metal-free click reaction at the interface of an inverse miniemulsion. By this unique approach, high encapsulation efficiency without harming the cargo during the nanocarrier formation process and regardless of their physical properties is achieved, thus keeping their bioactivity. Furthermore, we demonstrated high control over the encapsulation efficiency and varying the amount of each cargo did not influence the efficiency of multicomponent encapsulation. Azide-modified HSA was crosslinked with hexanediol dipropiolate (HDDP) at the interface of a water-in-oil miniemulsion. Varying the crosslinker amount allowed us to tailor the density and degradation rates of the protein shell. Additional installation of disulfide bonds into the crosslinker created redox-responsive nanocarriers, which degraded both by protease and under reducing conditions with dithiothreitol. The prepared HSA nanocarriers were efficiently taken up by dendritic cells and exhibited an additive cell activation and maturation, exceeding the nanocarriers loaded with only a single drug. This general protocol allows the orthogonal and metal-free encapsulation of various drugs or adjuvants at defined concentrations into the protein nanocarriers.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据